Ginette Tardif
- Rheumatology top 0.2%
- Molecular Biology top 10%
- Pharmacology top 1%
- Cancer Research top 2%
- Oncology top 5%
- Co-authors
- Johanne Martel‐PelletierJean‐Pierre PelletierPascal ReboulJ.-P. PelletierJ M CloutierFrançois MineauChangshan GengDavid Hum
- Topics
- Osteoarthritis Treatment and Mechanisms (37 papers)Inflammatory mediators and NSAID effects (16 papers)TGF-β signaling in diseases (8 papers)
- Journals
- Journal of Clinical InvestigationApplied and Environmental MicrobiologyThe Journal of Clinical Endocrinology & Metabolism
- Partner nations
- CanadaUnited StatesSpain
In The Last Decade
Ginette Tardif
53 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 111
- Rheumatology 1.9k
- Molecular Biology 1.1k
- Pharmacology 795
- Cancer Research 746
- Oncology 460
Countries citing papers authored by Ginette Tardif
This map shows the geographic impact of Ginette Tardif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ginette Tardif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ginette Tardif more than expected).
Fields of papers citing papers by Ginette Tardif
This network shows the impact of papers produced by Ginette Tardif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ginette Tardif. The network helps show where Ginette Tardif may publish in the future.
Co-authorship network of co-authors of Ginette Tardif
This figure shows the co-authorship network connecting the top 25 collaborators of Ginette Tardif. A scholar is included among the top collaborators of Ginette Tardif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ginette Tardif. Ginette Tardif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 20 | |
| 2 | 7 | |
| 3 | 32 | |
| 4 | 13 | |
| 5 | 20 | |
| 6 | 59 | |
| 7 | 198 | |
| 8 | 34 | |
| 9 | 20 | |
| 10 | 18 | |
| 11 | 15 | |
| 12 | 83 | |
| 13 | 47 | |
| 14 | 10 | |
| 15 | 40 | |
| 16 | 181 | |
| 17 | 28 | |
| 18 | 72 | |
| 19 | 35 | |
| 20 | 168 |
About Ginette Tardif
Ginette Tardif is a scholar working on Rheumatology, Pharmacology and Cancer Research, having authored 53 papers that have together received 3.2k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (37 papers), Inflammatory mediators and NSAID effects (16 papers) and TGF-β signaling in diseases (8 papers). The work is most often cited by research in Rheumatology (1.9k citations), Cancer Research (746 citations) and Pharmacology (795 citations). Ginette Tardif has collaborated with scholars based in Canada, United States and Spain. Frequent co-authors include Johanne Martel‐Pelletier, Jean‐Pierre Pelletier, Pascal Reboul, J.-P. Pelletier, J M Cloutier, François Mineau, Changshan Geng, David Hum, Pierre Ranger and Johanne Martel‐Pelletier. Their work appears in journals such as Journal of Clinical Investigation, Applied and Environmental Microbiology and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.